Hematologic Malignancies Program

Download Hematologic Malignancies Program PDF

 

HOSPITAL
University Hospitals Seidman Cancer Center

KEY CONTACTS
Brenda Cooper, MD, Disease Team Leader, Medical Oncology 216-844-3213, Brenda.Cooper@UHhospitals.org
Marcos de Lima, MD, Director, Stem Cell Transplant 216-844-0139, Marcos.deLima@UHhospitals.org

For hospital transfers, please call 216-844-1111.

Conditions Treated

  • Leukemia
    Acute lymphoblastic leukemia
    Acute myeloid leukemia
    Chronic lymphocytic leukemia
    Chronic myelogenous leukemia
  • Lymphomas
    Non-Hodgkin lymphoma
    Hodgkin lymphoma
    Primary CNS lymphoma
  • Myeloma
  • Marrow failure syndromes

Therapies

  • Stem cell transplantation and other novel cellular therapies
  • Biological therapy
  • Radiation therapy
  • Chemotherapy

Distinguishing Features

  • Part of NCI-designated Case Comprehensive Cancer Cente
  • Accredited by the Foundation for the Accreditation of Cellular Therap
  • Partner with National Center for Stem Cell and Regenerative Medicine to study and develop new stem cell-based therapies
  • Stem Cell Transplant Clinical Trials Network member
  • University Hospitals Rainbow Babies & Children’s Hospital member of the Pediatric Blood and Stem Cell Transplant Consortium
  • Specialized Adolescent and Young Adult (AYA) cancer program
  • Extensive portfolio of clinical trials of new treatments